These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34563949)

  • 1. Depletion of β3-adrenergic receptor relieves pressure overload-induced cardiac hypertrophy and heart failure via enhancing innate immune response.
    Wei X; Zhang A; Yang W; Fang Y
    Biomed Pharmacother; 2021 Nov; 143():112194. PubMed ID: 34563949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of β3-adrenergic receptor induces left ventricular diastolic dysfunction via potential regulation of energy metabolism and cardiac contraction.
    Yang W; Wei X; Su X; Shen Y; Jin W; Fang Y
    Gene; 2019 May; 697():1-10. PubMed ID: 30790654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
    Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
    Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.
    Velten M; Duerr GD; Pessies T; Schild J; Lohner R; Mersmann J; Dewald O; Zacharowski K; Klaschik S; Hilbert T; Hoeft A; Baumgarten G; Meyer R; Boehm O; Knuefermann P
    Cardiovasc Res; 2012 Dec; 96(3):422-32. PubMed ID: 22977006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
    Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
    Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling.
    Nagai T; Anzai T; Mano Y; Kaneko H; Anzai A; Sugano Y; Maekawa Y; Takahashi T; Yoshikawa T; Fukuda K
    Heart Vessels; 2013 May; 28(3):404-11. PubMed ID: 22875408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.
    Zhao D; Zhong G; Li J; Pan J; Zhao Y; Song H; Sun W; Jin X; Li Y; Du R; Nie J; Liu T; Zheng J; Jia Y; Liu Z; Liu W; Yuan X; Liu Z; Song J; Kan G; Li Y; Liu C; Gao X; Xing W; Chang YZ; Li Y; Ling S
    Circulation; 2021 Aug; 144(9):694-711. PubMed ID: 34139860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
    Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
    J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac Hypertrophy but Requires Mitochondrial Antiviral Signaling Protein for Signal Transductions and Energy Balance.
    Lin HB; Naito K; Oh Y; Farber G; Kanaan G; Valaperti A; Dawood F; Zhang L; Li GH; Smyth D; Moon M; Liu Y; Liang W; Rotstein B; Philpott DJ; Kim KH; Harper ME; Liu PP
    Circulation; 2020 Dec; 142(23):2240-2258. PubMed ID: 33070627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
    Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
    Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.
    Taglieri DM; Johnson KR; Burmeister BT; Monasky MM; Spindler MJ; DeSantiago J; Banach K; Conklin BR; Carnegie GK
    J Mol Cell Cardiol; 2014 Jan; 66():27-40. PubMed ID: 24161911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
    Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
    Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Observation of Liver and Kidney Injury and the Activation of Macrophages in the Overload Pressure Induced Cardiac Hypertrophy/Heart Failure Mouse Model].
    Quan Y; Tian GE; Zhou JT; Wu WC; Liu XJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):331-336. PubMed ID: 32543138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
    Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Ishino M; Bilim O; Suzuki S; Sasaki T; Nakajima O; Walsh RA; Goto K; Kubota I
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H245-55. PubMed ID: 18487437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.
    Zhang L; Liu M; Jiang H; Yu Y; Yu P; Tong R; Wu J; Zhang S; Yao K; Zou Y; Ge J
    J Cell Mol Med; 2016 Mar; 20(3):459-70. PubMed ID: 26647902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation.
    Wang B; Xu M; Li W; Li X; Zheng Q; Niu X
    PLoS One; 2017; 12(6):e0179648. PubMed ID: 28622359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
    You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular TLR4 Levels Abrogate TLR2-Mediated Adverse Cardiac Remodeling upon Pressure Overload in Mice.
    Kessler EL; Wang JW; Kok B; Brans MA; Nederlof A; van Stuijvenberg L; Huang C; Vink A; Arslan F; Efimov IR; Lam CSP; Vos MA; de Kleijn DPV; Fontes MSC; van Veen TAB
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.